{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:54:25Z","timestamp":1773212065547,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Friedrich Baur foundation"},{"name":"Bettina Br\u00e4u foundation"},{"name":"G\u00e4nsebl\u00fcmchen-Voerde foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12072-015-9686-1","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T04:13:25Z","timestamp":1449634405000},"page":"370-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma"],"prefix":"10.1007","volume":"10","author":[{"given":"Jan","family":"G\u00f6deke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Luxenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Trippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"H\u00e4berle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"M\u00fcller-H\u00f6cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"von Schweinitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Kappler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"9686_CR1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-62703-116-5_11","volume-title":"Pediatric neoplasia: advances in molecular pathology and translational medicine, molecular and translational medicine","author":"D Lopez-Terrada","year":"2012","unstructured":"Lopez-Terrada D. Hepatoblastoma: new insights into the biology of embryonal tumors of the liver. In: Mackinnon Jr. A, editor. Pediatric neoplasia: advances in molecular pathology and translational medicine, molecular and translational medicine. New York: Springer Science\u00a0+\u00a0Business Media; 2012. p. 243"},{"issue":"3","key":"9686_CR2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/jhep.2003.50375","volume":"38","author":"A Darbari","year":"2003","unstructured":"Darbari A, Sabin K, Shapiro C, Schwarz K. Epidemiology of primary hepatic malignancies in US children. Hepatology. 2003;38(3):560\u2013566","journal-title":"Hepatology"},{"issue":"6","key":"9686_CR3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0046-8177(83)80005-7","volume":"14","author":"A Weinberg","year":"1983","unstructured":"Weinberg A, Finegold M. Primary hepatic tumors of childhood. Hum Pathol. 1983;14(6):512\u2013537","journal-title":"Hum Pathol"},{"key":"9686_CR4","doi-asserted-by":"crossref","unstructured":"Lopez-Terrada D, Finegold M. Tumors of the liver. In: Liver disease in children. New York: Cambridge University Press. 2007, p. 943\u2013975","DOI":"10.1017\/CBO9780511547409.042"},{"key":"9686_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2741\/e395","volume":"4","author":"B Haeberle","year":"2012","unstructured":"Haeberle B, von Schweinitz D. Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies. Front Biosci (Elite ed.). 2012;4:493\u2013498","journal-title":"Front Biosci (Elite ed.)"},{"key":"9686_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1470-2045(00)00018-8","volume":"1","author":"G Perilongo","year":"2000","unstructured":"Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol. 2000;1:94\u2013100","journal-title":"Lancet Oncol"},{"issue":"24","key":"9686_CR7","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1200\/JCO.2010.29.3837","volume":"29","author":"M Malogolowkin","year":"2011","unstructured":"Malogolowkin M, et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the children\u2019s oncology group. J Clin Oncol. 2011;29(24):3301\u20133306","journal-title":"J Clin Oncol"},{"issue":"6","key":"9686_CR8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenm\u00fcller","year":"2014","unstructured":"Eichenm\u00fcller M, et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol. 2014;61(6):1312\u20131320","journal-title":"J Hepatol"},{"issue":"2","key":"9686_CR9","first-page":"269","volume":"59","author":"A Koch","year":"1999","unstructured":"Koch A, et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res. 1999;59(2):269\u2013273","journal-title":"Cancer Res"},{"issue":"14","key":"9686_CR10","first-page":"3320","volume":"56","author":"H Oda","year":"1996","unstructured":"Oda H, et al. Somatic mutations of the APC gene in sporadic hepatoblastomas. Cancer Res. 1996;56(14):3320\u20133323","journal-title":"Cancer Res"},{"issue":"31","key":"9686_CR11","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","volume":"21","author":"K Taniguchi","year":"2002","unstructured":"Taniguchi K, et al. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002;21(31):4863\u20134871","journal-title":"Oncogene"},{"issue":"3","key":"9686_CR12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ijc.11228","volume":"106","author":"Y Deng","year":"2003","unstructured":"Deng Y, et al. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer. 2003;106(3):342\u2013347","journal-title":"Int J Cancer"},{"issue":"16","key":"9686_CR13","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","volume":"65","author":"E Lusis","year":"2005","unstructured":"Lusis E, et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res. 2005;65(16):7121\u20137126","journal-title":"Cancer Res"},{"key":"9686_CR14","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1074\/jbc.M110.170803","volume":"286","author":"J Hwang","year":"2011","unstructured":"Hwang J, et al. Crystal structure of the human N-Myc downstream-regulated gene 2 protein provides insight into its role as a tumor suppressor. J Biol Chem. 2011;286:12450\u201312460","journal-title":"J Biol Chem"},{"key":"9686_CR15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/geno.2000.6496","volume":"73","author":"R Zhou","year":"2001","unstructured":"Zhou R, et al. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics. 2001;73:86\u201397","journal-title":"Genomics"},{"key":"9686_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1017934810825","volume":"229","author":"X Qu","year":"2002","unstructured":"Qu X, et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem. 2002;229:35\u201344","journal-title":"Mol Cell Biochem"},{"key":"9686_CR17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0014-5793(03)01030-5","volume":"553","author":"S Choi","year":"2003","unstructured":"Choi S, et al. Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett. 2003;553:413\u2013418","journal-title":"FEBS Lett"},{"key":"9686_CR18","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.3748\/wjg.v10.i23.3518","volume":"10","author":"X Hu","year":"2004","unstructured":"Hu X, et al. NDRG2 expression and mutation in human liver and pancreatic cancers. World J Gastroenterol. 2004;10:3518\u20133521","journal-title":"World J Gastroenterol"},{"key":"9686_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13000-014-0209-5","volume":"9","author":"N Li","year":"2014","unstructured":"Li N, et al. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma. Diagn Pathol. 2014;9:209","journal-title":"Diagn Pathol"},{"key":"9686_CR20","first-page":"1","volume":"251","author":"J Zheng","year":"2011","unstructured":"Zheng J, et al. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression. BMC Cancer. 2011;251:1\u20139","journal-title":"BMC Cancer"},{"key":"9686_CR21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbrc.2007.04.089","volume":"358","author":"N Liu","year":"2007","unstructured":"Liu N, et al. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. Biochem Biophys Res Commun. 2007;358:164\u2013169","journal-title":"Biochem Biophys Res Commun"},{"key":"9686_CR22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/hep.22649","volume":"49","author":"M Eichenm\u00fcller","year":"2009","unstructured":"Eichenm\u00fcller M, et al. Blocking the hedgehog pathway inhibits hepatoblastoma growth. Hepatology. 2009;49:482\u2013490","journal-title":"Hepatology"},{"issue":"9","key":"9686_CR23","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/nprot.2007.314","volume":"2","author":"J Tost","year":"2007","unstructured":"Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc. 2007;2(9):2265\u20132275","journal-title":"Nat Protoc"},{"issue":"1","key":"9686_CR24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbrc.2013.10.010","volume":"441","author":"A Yamamura","year":"2013","unstructured":"Yamamura A, et al. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. Biochem Biophys Res Commun. 2013;441(1):102\u2013107","journal-title":"Biochem Biophys Res Commun"},{"key":"9686_CR25","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1038\/ncomms4393","volume":"5","author":"S Nakahata","year":"2014","unstructured":"Nakahata S, et al. Loss NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers. Nat Commun. 2014;5:3393","journal-title":"Nat Commun"},{"key":"9686_CR26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2741\/e459","volume":"4","author":"G Tomlinson","year":"2012","unstructured":"Tomlinson G. Cytogenetics of hepatoblastoma. Front Biosci (Elite ed.). 2012;4:1287\u20131292","journal-title":"Front Biosci (Elite ed.)"},{"issue":"2","key":"9686_CR27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)64567-1","volume":"157","author":"R Weber","year":"2000","unstructured":"Weber R, Pietsch T, von Schweinitz D, Lichter P. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol. 2000;157(2):571\u2013578","journal-title":"Am J Pathol"},{"issue":"11","key":"9686_CR28","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1158\/0008-5472.CAN-07-5040","volume":"68","author":"D Lee","year":"2008","unstructured":"Lee D, et al. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res. 2008;68(11):4210\u20134220","journal-title":"Cancer Res"},{"key":"9686_CR29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/emm.2007.77","volume":"39","author":"S Choi","year":"2007","unstructured":"Choi S, et al. Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med. 2007;39:705\u2013714","journal-title":"Exp Mol Med"},{"key":"9686_CR30","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1101\/gad.14.15.1837","volume":"14","author":"P Polakis","year":"2000","unstructured":"Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837\u20131851","journal-title":"Genes Dev"},{"key":"9686_CR31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/carcin\/bgp072","volume":"30","author":"A Kim","year":"2009","unstructured":"Kim A, et al. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis. 2009;30:927\u2013936","journal-title":"Carcinogenesis"},{"issue":"22","key":"9686_CR32","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1016\/j.febslet.2012.09.045","volume":"586","author":"J Kim","year":"2012","unstructured":"Kim J, et al. NDRG2 and PRA1 interact and synergistically inhibit T-cell factor\/\u03b2-catenin signaling. FEBS Lett. 2012;586(22):3962\u20133968","journal-title":"FEBS Lett"},{"key":"9686_CR33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/carcin\/bgp047","volume":"30","author":"Y Kim","year":"2009","unstructured":"Kim Y, et al. NDRG2 expression decreases with tumor stages and regulates TCF\/beta-catenin signaling in human colon carcinoma. Carcinogenesis. 2009;30:598\u2013605","journal-title":"Carcinogenesis"},{"key":"9686_CR34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2009.05.038","volume":"385","author":"S Shon","year":"2009","unstructured":"Shon S, et al. Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun. 2009;385:198\u2013203","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"9686_CR35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1615\/ForumImmunDisTher.v1.i3.10","volume":"1","author":"Q Du","year":"2010","unstructured":"Du Q, Geller D. Cross-regulation between Wnt and NF-\u03baB signaling pathways. For Immunopathol Dis Therap. 2010;1(3):155\u2013181","journal-title":"For Immunopathol Dis Therap"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9686-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-015-9686-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9686-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T16:31:49Z","timestamp":1653755509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-015-9686-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["9686"],"URL":"https:\/\/doi.org\/10.1007\/s12072-015-9686-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]}}}